Watch Ticker

Gain Therapeutics, Inc. Common Stock

Go to Gain Therapeutics, Inc. Common Stock Website

$1.67

0.20 (13.61%)

Live

Previous Close

$1.67

Day Range

$1.43 - $1.67

Previous Day Range

$1.4137 - $1.5

Market Cap

$50.8 million USD

Day Vol.

366572

Previous Day Vol.

171202

Currency

USD

Primary Exchange

Nasdaq

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncol...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson’s Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers

Gain Therapeutics presented positive Phase 1 data for its lead drug candidate GT-02287, which showed an increase in GCase activity in healthy volunteers, supporting its potential as a disease-modifying treatment for Parkinson's disease.

Related tickers: GANX.

Read Full Article

N/A - Gain Therapeutics To Host Virtual Webinar on Results From Phase 1 Study and Design of Upcoming Phase 1b Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease

Gain Therapeutics, a clinical-stage biotechnology company, will host a webinar to discuss positive results from a Phase 1 study of its lead drug candidate GT-02287 for Parkinson's disease and the design of an upcoming Phase 1b trial.

Related tickers: GANX.

Read Full Article

Trending Tickers

Please sign in to view